Dr. Alexander-Bloch investigates normal brain development and the altered developmental trajectories that lead to mental illness. His multi-disciplinary research integrates brain imaging, genomics and clinical information.

The research interests of Dr. Allen include lung function testing in children, adolescents, and infants; developmental chest wall physiology; pulmonary complications of sickle cell disease; and complications of cystic fibrosis.

Dr. Almasy's work involves statistical genetic studies of addiction, autism, schizophrenia, and related quantitative risk factors.

Dr. Amaral's research is focused on kidney transplantation with particular interests in reducing treatment burden for adolescents and young adults — from designing studies to make daily medication regimens easier to diagnosing transplant injury earlier using innovative, noninvasive approaches.

Dr. Anari has research interests in pediatric chest wall and spinal deformities. His current research projects include understanding how children respond overall to chest wall surgery in thoracic insufficiency. He's working to identify which patients with early-onset scoliosis are at risk for unplanned surgery in an attempt to limit anesthesia exposure to the developing brain.

Dr. Anderson’s research interests focus on the molecular and cellular mechanisms that govern the development of the mammalian forebrain. In his research on the development of the cerebral cortex, he is particularly interested in understanding the molecular underpinnings behind the fate determination and axon targeting of subclasses of GABAergic interneurons implicated in the neuropathology of schizophrenia.

As vice chair of clinical research in the Department of Radiology, Dr. Andronikou oversees a growing translational and clinical research program that is broadly related to and impacts nearly every pediatric subspecialty. This program includes interventional radiology, cardiovascular, lymphatic imaging, pulmonary imaging, and oncology, among many others.

As a bioengineer, Dr. Arbogast's research focuses on pediatric injury biomechanics, injury causation and the effectiveness of safety products for children with a concentration in the safety of children and youth in motor vehicle crashes as well as pediatric concussion.

Dr. Argon investigates the unfolded protein response (UPR) , an essential signaling network that determines life or death of stressed cells and tissues. The IRE1 sensor of UPR responds to metabolic stress through four distinct activities and he focuses on determining which stress condition induces each activity and how they are integrated to enable the cells to cope with stress.

Dr. Arkader is one of few orthopedic surgeons in the country with formal training in both pediatric orthopedics and orthopedic oncology. He has a special interest in complex trauma and limb deformities, and specializes in external fixation methods and other minimally invasive techniques for limb preservation and equalization benefiting growing children.

Dr. Avery is a principal investigator and an an attending physician in the Division of Ophthalmology at Children’s Hospital of Philadelphia.

Dr. Avitabile works to understand the impact of musculoskeletal deficits on exercise performance in children with complex heart and lung diseases. She also participates in multi-centered clinical trials to advance the care of children with pediatric pulmonary hypertension. 

Dr. Back's research focuses on ultrasound and advanced ultrasound applications as well as genitourinary imaging.

Dr. Bagatell’s research focuses on improving therapies for children with neuroblastoma. She leads clinical research studies designed to critically evaluate current therapies for children with high-risk and relapsed disease, and is committed to conducting studies of new therapies for this population. She is currently pursuing research designed to evaluate biomarkers for response to targeted therapy in children with high-risk disease.

Dr. Bailey’s research centers on the development of learning health systems. This endeavor includes the creation of methods to share data across hospitals, recognize the clinical implications of information gathered from different sources, and provide support to clinicians to use this information more effectively.

Dr. Bailis aims to understand how metabolism underlies immunology and disease, by controlling the biochemistry of cells and tissues. His lab does so using in vitro and in vivo CRISPR engineering of primary human and mouse immune cells, with the goal of developing diet and metabolite based therapies.

Dr. Baker is a physicist with specialization in optics in biological tissues whose research in biomedical optics aims to develop and translate optical tools for clinical use. He also studies the interplay between the delivery of pediatric critical care and the patient’s long-term brain health.

Dr. Balamuth is a key institutional leader in pediatric sepsis and a rising national leader in pediatric sepsis recognition and care.

Dr. Baldassano’s research focuses on children who have inflammatory bowel diseases, and he oversees a large team of researchers at CHOP working to translate discoveries in the laboratory into direct patient care for children. One promising area of current research involves investigating the intestinal microbiomes of children with inflammatory bowel diseases.

Dr. Baldwin is an orthopaedic surgeon who specializes in the treatment of traumatic, neuromuscular, and spinal conditions in children.

Dr. Balis's research focuses on the clinical pharmacology of anticancer drugs, new drug development, and clinical trial design and endpoints. He studies the pharmacokinetics and pharmacodynamics of anticancer drugs and has applied pharmacological principles to clinical trial design and clinical drug development. He is developing new biomarkers to serve as surrogate endpoints of drug toxicity or efficacy in clinical trials.

Dr. Bamat’s research interest is neonatal respiratory failure, with an emphasis on pharmacotherapies for severe bronchopulmonary dysplasia and continuous distending airway pressure levels in infants requiring respiratory support.

A clinician-investigator and chief of the Division Neurology, Dr.Banwell's research interests center on multiple sclerosis onset during childhood and its impact.

Dr. Barakat's research is focused on examining risk-and-resilience models to characterize disease management and health-related quality of life of children with chronic health conditions and their families. Another focus of investigation is translation of these models into evidence-based assessment (family psychosocial risk screening) as well as family-based, mHealth interventions to improve disease management and to support medical decision-making for youth with cancer and their families.

Dr. Barret's research program focuses on immune function of children with cancer. His research involves investigating possible immune deficiencies that result in children developing cancer and developing immune-based therapies for childhood cancer.

Keith Bartley is a computer science engineer and data scientist who co-leads the Technology and Innovation program of the Center for Autism Research.

Dr. Barzilay aims to understand what drives variability in the development of brain and behavior of youths growing up under stress. He studies biological and environmental mechanisms leading to suicidal behavior, using big datasets of diverse genotyped youths with deep phenotyping of environment.

Dr. Bassing's research program focuses on the genetic, epigenetic, and biochemical mechanisms by which mammals develop their immune systems while suppressing autoimmunity and genomic aberrations that cause leukemia or lymphoma.

Dr. Bassiri studies the ways in which the immunometabolic features of lymphocytes are altered within solid tumor environments, and how modulating these features may enhance anti-tumor immunity.

Dr. Bauer's academic and clinical career are focused on improving the care of children and adolescents with thyroid disease. He has extensive experience and knowledge of thyroid pathophysiology and tumorigenesis, and has been critical to the clinical success of the Children's Hospital of Philadelphia Thyroid Center.

Dr. Behrens' research focuses on the pathogenesis and treatment of cytokine storm syndromes, including the hemophagocytic syndromes Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS).

Dr. Belasco’s clinical and research work focuses on pediatric cancers, palliative care, neuro-oncology, neurofibromatosis, and lymphatic vascular malformations.

Dr. Bell, chief of the Division of General Pediatrics, has research expertise in areas including computerized clinical decision support to improve the quality of care; epidemiology, management and treatment of common pediatric infectious diseases; the use of primary care practice-based research networks for clinical research; and quality improvement through the use of clinical pathways.

Dr. Benitez is currently building a comprehensive translational research program in which he hopes to study the role of brain-gut-microbiome and microbiome-mucosal interactions in the development of functional GI and motility disorders.

Dr. Bennett’s research interests include screening for medical and behavioral co-morbidities in individuals with developmental disabilities, with specific interest in improving screening and outcome measures for children with autism spectrum disorder.

Dr. Benton's research focuses primarily on pediatric mood and anxiety disorders, sickle cell disease and psychiatric conditions, HIV and psychiatric conditions, neuroimmunology and mood disorders, health services research, eating disorders, and ethnically diverse children.

Dr. Berg is a resuscitation scientist with extensive clinical and preclinical translational laboratory experience in the areas of cardiac arrest, VF, defibrillation, and personalized physiologic-directed CPR. He has substantial expertise in conducting multicenter observational and interventional trials.

Dr. Berger's research focus involves the development of pediatric heart failure and underlying metabolic drivers. He studies how improving metabolic dysregulation may also benefit cardiac dysfunction.